Related Experiment Video
Updated: May 16, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Detecting familial hypercholesterolaemia in general practice
Andrew Kirke1, Gerald F Watts, Jon Emery
1Rural Clinical School of Western Australia, University of Western Australia, Bunbury, Western Australia. andrew.kirke@rcswa.edu.au
Insights
Familial hypercholesterolaemia (FH) screening is crucial for preventing early heart disease. General practitioners can implement opportunistic or systematic screening methods to diagnose more FH cases.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Familial hypercholesterolaemia (FH) is a common genetic disorder leading to premature coronary artery disease.
- A significant number of FH cases remain undiagnosed, highlighting a gap in detection.
- Existing FH clinical guidelines require adaptation for Australian general practice.
Purpose of the Study:
- To review and contextualize screening approaches for Familial hypercholesterolaemia (FH) within Australian general practice.
- To evaluate opportunistic and systematic screening strategies for FH in primary care settings.
Main Methods:
- Literature review of current evidence on FH screening.
- Analysis of four distinct screening approaches: opportunistic (family history, lipid screening) and systematic (electronic records, universal child screening).
Main Results:
- General practitioners are positioned to initiate FH screening.
- Multiple screening avenues exist, including opportunistic family history and lipid checks.
- Systematic approaches like electronic record searches and universal child screening are viable.
- Specialist lipid clinics play a key role in managing diagnosed FH patients.
Conclusions:
- General practice is an ideal setting for implementing FH screening programs.
- A combination of opportunistic and systematic screening methods can improve FH detection rates.
- Effective management of FH requires collaboration between general practitioners and specialist lipid clinics.
Background:
Familial hypercholesterolaemia (FH) is a relatively common inherited cause of premature coronary artery disease. However, a significant number of people remain undiagnosed. Several clinical guidelines on FH have been published recently, but these need to be placed in context for Australian general practitioners.
Objective:
We review four possible approaches to screening for FH in the general practice setting: two opportunistic and two systematic. Evidence for these screening approaches is drawn from the current literature on FH.
Discussion:
General practitioners are well placed to institute screening for FH in the general practice setting. Screening approaches could include opportunistic screening for family history, opportunistic screening of lipids, systematic searching of general practice electronic records, and universal screening of children. The role of specialist lipid clinics is important in the GP management of patients with FH.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
